Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Dickstein

Showing results (1-10 of 372) with videos related to

Pageof 38
Sort By:
International Journal of Cardiology|November 7, 2002
Angiotensin receptor blockers--finally the evidence is coming in: IDNT and RENAALKenneth Dickstein
Current Controlled Trials in Cardiovascular Medicine|January 25, 2002
ELITE II and Val-HeFT are different trials: together what do they tell us?Kenneth Dickstein
Lancet (London, England)|August 23, 2011
Cardiac myosin activation: will theory and practice coincide?Kenneth Dickstein
Circulation. Heart Failure|July 22, 2010
Response to Coceani: Cardiac resynchronization therapy has earned its class I recommendation and continues to thrive under scrutinyKenneth Dickstein
American Heart Journal|May 27, 2003
What did we learn from the OPTIMAAL trial? What can we expect from VALIANT?Kenneth Dickstein
European Heart Journal|October 12, 2017
Heartfailurematters.orgKenneth Dickstein
European Journal of Heart Failure|May 27, 2017
Early clinical benefit after cardiac resynchronization therapy: fortunately, QRS width and ejection fraction are still the best predictorsKenneth Dickstein
F1000 Medicine Reports|October 16, 2010
Remote monitoring of patients with cardiac failureKenneth Dickstein
European Journal of Heart Failure|February 21, 2006
Clinical trials update from the European Society of Cardiology Meeting 2005: CIBIS-III. Response to correspondence from R. Willenheimer et alKenneth Dickstein
Journal of the American College of Cardiology|October 10, 2009
Diagnosing acute heart failure: the mathematician and the clinicianKenneth Dickstein
Pageof 38

Showing results (1-10 of 372) with videos related to

Sort By:
Pageof 38
International Journal of Cardiology|November 7, 2002
Angiotensin receptor blockers--finally the evidence is coming in: IDNT and RENAALKenneth Dickstein
Current Controlled Trials in Cardiovascular Medicine|January 25, 2002
ELITE II and Val-HeFT are different trials: together what do they tell us?Kenneth Dickstein
Lancet (London, England)|August 23, 2011
Cardiac myosin activation: will theory and practice coincide?Kenneth Dickstein
Circulation. Heart Failure|July 22, 2010
Response to Coceani: Cardiac resynchronization therapy has earned its class I recommendation and continues to thrive under scrutinyKenneth Dickstein
American Heart Journal|May 27, 2003
What did we learn from the OPTIMAAL trial? What can we expect from VALIANT?Kenneth Dickstein
European Heart Journal|October 12, 2017
Heartfailurematters.orgKenneth Dickstein
European Journal of Heart Failure|May 27, 2017
Early clinical benefit after cardiac resynchronization therapy: fortunately, QRS width and ejection fraction are still the best predictorsKenneth Dickstein
F1000 Medicine Reports|October 16, 2010
Remote monitoring of patients with cardiac failureKenneth Dickstein
European Journal of Heart Failure|February 21, 2006
Clinical trials update from the European Society of Cardiology Meeting 2005: CIBIS-III. Response to correspondence from R. Willenheimer et alKenneth Dickstein
Journal of the American College of Cardiology|October 10, 2009
Diagnosing acute heart failure: the mathematician and the clinicianKenneth Dickstein
Pageof 38